In addition, other molecules capable of counteracting the antiapoptotic effect, such as Bim, are expressed in low amounts in CML cells but their expression is increased when BCR–ABL is inhibited [66]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.